{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:56:24Z","timestamp":1793973384023,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Hong Kong Food Bureau","doi-asserted-by":"publisher","award":["CID-CUHK-D"],"award-info":[{"award-number":["CID-CUHK-D"]}],"id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jhep.2024.11.018","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T12:40:38Z","timestamp":1732106438000},"page":"992-1003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"82","author":[{"given":"Jimmy Che-To","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Lai-Hung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Kit","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki Wing-Ki","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy Sze-Man","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Lik-Yuen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry Cheuk-Fung","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.11.018_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2012.02.033","article-title":"Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy","volume":"57","author":"Peng","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","author":"Wong","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.11.018_bib4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jhep.2015.06.026","article-title":"Optimal management of hepatitis B virus infection - EASL Special Conference","volume":"63","author":"Lampertico","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib6","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.11.018_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2024.11.018_bib8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","article-title":"Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase","volume":"20","author":"Huang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/jvh.13511","article-title":"Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone","volume":"28","author":"Yao","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2024.11.018_bib10","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MCG.0b013e3182a9a2e1","article-title":"Predictors of significant fibrosis in chronic hepatitis B patients with low viremia","volume":"48","author":"Abdo","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2024.11.018_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/jvh.13873","article-title":"Clinical and histological features of patients with chronic hepatitis B virus infection in the grey zone","volume":"30","author":"Gan","year":"2023","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2024.11.018_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.102071","article-title":"Transarterial chemoembolization failure in patients with hepatocellular carcinoma: incidence, manifestation and risk factors","volume":"47","author":"Zhang","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2024.11.018_bib13","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/HEP.0000000000000459","article-title":"Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase","volume":"78","author":"Huang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.11.018_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/liv.14001","article-title":"Clinical outcomes and management of patients with chronic hepatitis B and liver stiffness measurement in the grey zone","volume":"39","author":"Liu","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.11.018_bib15","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2024.11.018_bib16","author":"Wells"},{"key":"10.1016\/j.jhep.2024.11.018_bib17","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2024.11.018_bib18","series-title":"JBI manual for evidence synthesis","article-title":"Chapter 7: systematic reviews of etiology and risk","author":"Moola","year":"2020"},{"key":"10.1016\/j.jhep.2024.11.018_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.jhep.2024.11.018_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/EDE.0000000000001232","article-title":"Meta-analysis of proportions using generalized linear mixed models","volume":"31","author":"Lin","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.jhep.2024.11.018_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11606-021-07098-5","article-title":"Empirical comparisons of 12 meta-analysis methods for synthesizing proportions of binary outcomes","volume":"37","author":"Lin","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jhep.2024.11.018_bib22","first-page":"94","article-title":"The impact of studies with no events in both arms on meta-analysis of rare events: a simulation study using generalized linear mixed model","volume":"5","author":"Xu","year":"2023","journal-title":"Res Methods Med Health Sci"},{"key":"10.1016\/j.jhep.2024.11.018_bib23","series-title":"Flexible imputation of missing data","author":"Sv","year":"2018"},{"key":"10.1016\/j.jhep.2024.11.018_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib25","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1002\/hep.22884","article-title":"Hepatitis B virus DNA levels and outcomes in chronic hepatitis B","volume":"49","author":"Chen","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.11.018_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cgh.2008.10.023","article-title":"Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients","volume":"7","author":"Wong","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib27","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.11.018_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.2007.128496","article-title":"Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years","volume":"57","author":"Fattovich","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.11.018_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3350\/cmh.2020.0216","article-title":"Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B","volume":"27","author":"Jeon","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2020.10.022","article-title":"Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B","volume":"84","author":"Lee","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhep.2024.11.018_bib31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cgh.2007.01.005","article-title":"Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome","volume":"5","author":"Andreani","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib33","article-title":"The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: a systematic review and meta-analysis","volume":"13","author":"Liu","year":"2023","journal-title":"Front Cel Infect Microbiol"},{"key":"10.1016\/j.jhep.2024.11.018_bib34","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1200\/JCO.2005.01.9927","article-title":"An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results","volume":"23","author":"Mok","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2024.11.018_bib35","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2009.27.4456","article-title":"Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection","volume":"28","author":"Yang","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2024.11.018_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhep.2014.08.045","article-title":"Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis","volume":"61","author":"Xiao","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.11.018_bib38","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1136\/gutjnl-2020-321309","article-title":"Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B","volume":"70","author":"Kim","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.11.018_bib39","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jvh.13843","article-title":"Cost-effectiveness of treating all hepatitis B-positive individuals in the United States","volume":"30","author":"Razavi-Shearer","year":"2023","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2024.11.018_bib40","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/hep.31554","article-title":"Low incidence of adverse outcomes in adults with chronic hepatitis B virus infection in the era of antiviral therapy","volume":"73","author":"Lok","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.11.018_bib41","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1111\/jgh.15664","article-title":"Secular trend of treatment uptake in patients with chronic hepatitis B: a territory-wide study of 135 395 patients from 2000 to 2017","volume":"36","author":"Lai","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.11.018_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2893.2011.01450.x","article-title":"Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion","volume":"19","author":"Chen","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2024.11.018_bib43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jhep.2010.07.033","article-title":"Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy","volume":"54","author":"Tsochatzis","year":"2011","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824027181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824027181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:02:05Z","timestamp":1773457325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824027181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0168827824027181"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.11.018","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}